ATE163421T1 - Tocopherol-analoge mit cardioprotectiver wirkung - Google Patents

Tocopherol-analoge mit cardioprotectiver wirkung

Info

Publication number
ATE163421T1
ATE163421T1 AT92402656T AT92402656T ATE163421T1 AT E163421 T1 ATE163421 T1 AT E163421T1 AT 92402656 T AT92402656 T AT 92402656T AT 92402656 T AT92402656 T AT 92402656T AT E163421 T1 ATE163421 T1 AT E163421T1
Authority
AT
Austria
Prior art keywords
cardioprotection
effects
tocopherol analogues
tocopherol
analogues
Prior art date
Application number
AT92402656T
Other languages
German (de)
English (en)
Inventor
J Martin Grisar
Margaret A Petty
Frank Bolkenius
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of ATE163421T1 publication Critical patent/ATE163421T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Inspection Of Paper Currency And Valuable Securities (AREA)
  • Noodles (AREA)
  • Credit Cards Or The Like (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Fire-Detection Mechanisms (AREA)
AT92402656T 1991-10-02 1992-09-29 Tocopherol-analoge mit cardioprotectiver wirkung ATE163421T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91402630A EP0535283A1 (en) 1991-10-02 1991-10-02 Cardioprotective tocopherol analogs

Publications (1)

Publication Number Publication Date
ATE163421T1 true ATE163421T1 (de) 1998-03-15

Family

ID=8208620

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92402656T ATE163421T1 (de) 1991-10-02 1992-09-29 Tocopherol-analoge mit cardioprotectiver wirkung

Country Status (17)

Country Link
EP (2) EP0535283A1 (en:Method)
JP (1) JP3230699B2 (en:Method)
KR (1) KR100253108B1 (en:Method)
AT (1) ATE163421T1 (en:Method)
AU (1) AU652077B2 (en:Method)
CA (1) CA2079289C (en:Method)
DE (1) DE69224501T2 (en:Method)
DK (1) DK0536036T3 (en:Method)
ES (1) ES2115656T3 (en:Method)
FI (1) FI105552B (en:Method)
GR (1) GR3026242T3 (en:Method)
HU (1) HU215123B (en:Method)
IL (1) IL103305A0 (en:Method)
NO (1) NO923840L (en:Method)
NZ (1) NZ244549A (en:Method)
TW (1) TW224970B (en:Method)
ZA (1) ZA927429B (en:Method)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510373A (en) * 1992-04-06 1996-04-23 Merrell Pharmaceuticals Inc. Cardioprotective agents
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
US5545660A (en) * 1992-04-07 1996-08-13 Merrell Pharmaceuticals Inc. Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans
ES2244104T3 (es) * 1997-11-25 2005-12-01 Antipodean Biotechnology Limited Antioxidantes orientados mitocondrialmente.
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
US8008345B2 (en) 2001-07-27 2011-08-30 Vital Health Sciences Pty. Ltd. Dermal therapy using phosphate derivatives of electron transfer agents
ES2314010T3 (es) * 2002-06-19 2009-03-16 Cognis Ip Management Gmbh Empleo de mazclas de principios activos para la obtencion de un medicamento contra la artritis reumatoide.
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US7888334B2 (en) 2003-08-22 2011-02-15 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
CN1839142B (zh) 2003-08-22 2010-06-16 澳新制药公司 用作靶向线粒体的抗氧化剂的线粒体醌衍生物
US7514461B2 (en) 2003-09-19 2009-04-07 Edison Pharmaceuticals, Inc. Chroman derivatives
WO2005084678A1 (en) 2004-03-03 2005-09-15 Vital Health Sciences Pty Ltd Alkaloid formulations
EP1893159B1 (en) 2005-06-17 2015-09-30 Vital Health Sciences Pty Ltd. A carrier comprising one or more di- and/or monophosphate derivatives of electron transfer agents
US7813042B2 (en) 2005-09-12 2010-10-12 Sharp Kabushiki Kaisha Multiple-view directional display
WO2008029891A1 (en) 2006-09-07 2008-03-13 Sharp Kabushiki Kaisha Image display device, electronic device, and parallax barrier element
EP2531047B1 (en) 2010-02-05 2024-11-13 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
JP5806287B2 (ja) 2010-03-30 2015-11-10 フォスファジェニクス リミティド 経皮送達パッチ
EP2685992A4 (en) 2011-03-15 2014-09-10 Phosphagenics Ltd AMINOCHINOLINE AS A KINASEHEMMER
CN108601732A (zh) 2015-12-09 2018-09-28 磷肌酸有限公司 药物制剂
KR102647670B1 (ko) 2016-12-21 2024-03-15 아베초 바이오테크놀로지 리미티드 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62205091A (ja) * 1986-03-04 1987-09-09 Senjiyu Seiyaku Kk 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤
CA2002649C (en) * 1988-11-14 2000-06-06 Margaret Petty Cardioprotective tocopherol analogs
US5500444A (en) 1989-11-14 1996-03-19 Hoechst Marion Roussel, Inc. Cardioprotective tocopherol analogs
US5135945A (en) 1991-06-05 1992-08-04 Merrell Dow Pharmaceuticals Inc. Cholesterol-lowering tocopherol analogs

Also Published As

Publication number Publication date
NO923840L (no) 1993-04-05
DK0536036T3 (da) 1998-03-16
AU2538392A (en) 1993-04-08
EP0536036A1 (en) 1993-04-07
AU652077B2 (en) 1994-08-11
NO923840D0 (no) 1992-10-01
DE69224501D1 (de) 1998-04-02
ES2115656T3 (es) 1998-07-01
DE69224501T2 (de) 1998-06-25
CA2079289C (en) 2003-02-18
JP3230699B2 (ja) 2001-11-19
FI105552B (fi) 2000-09-15
CA2079289A1 (en) 1993-04-03
ZA927429B (en) 1993-04-07
GR3026242T3 (en) 1998-05-29
TW224970B (en:Method) 1994-06-11
EP0536036B1 (en) 1998-02-25
EP0535283A1 (en) 1993-04-07
JPH05310763A (ja) 1993-11-22
KR100253108B1 (ko) 2000-05-01
FI924424A0 (fi) 1992-10-01
HUT62592A (en) 1993-05-28
IL103305A0 (en) 1993-02-21
FI924424L (fi) 1993-04-03
HU9203134D0 (en) 1992-12-28
HU215123B (hu) 1998-09-28
NZ244549A (en) 1994-07-26

Similar Documents

Publication Publication Date Title
ATE163421T1 (de) Tocopherol-analoge mit cardioprotectiver wirkung
ATE68495T1 (de) 4,5,6,7-tetrahydro-1h-imidazo(4,5c>pyridinderivate und analoge mit antihypertensiver wirkung.
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
ES2191659T3 (es) Derivados heterociclicos substituidos utiles como inhibidores de la agregacion plaquetaria.
FR2757857B1 (fr) Diselenures et selenosulfures aromatiques, leur preparation et leurs utilisations, notamment therapeutiques
DE3882279D1 (de) Zyklisches antikoagulierendes peptid.
FI882359A0 (fi) Cykliska antikoagulationspeptider. pi path slues6208 s880524 mlues6205 m881102
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
EP0050286A3 (en) Novel pharmaceutical guanidine derivatives
ATE137230T1 (de) Ascorbinsäure derivate
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
ES2086395T3 (es) Fosfolipidos para el tratamiento de esclerosis multiple.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee